A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.


Updates from The Motley Fool

Latest updates on Harvard Bioscience from Fool.com.
Tomorrow's Monster Stock?

A list of promising companies chosen by investors who've already picked stocks that beat the mark...



Stock Performance

View Interactive HBIO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Harvard Bioscience.
Current Price: $2.65
Prev Close: $2.60
Open: $2.60
Bid: $2.60
Ask: $2.65
Day's Range: $2.60 - $2.70
52wk Range: $2.25 - $3.90
Volume: 12,264
Avg Vol 57,196
Market Cap: $92M
P/E (ttm): -20.00
EPS (ttm): ($0.13)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Harvard Bioscience.
CAPS Rating 2 out of 5
 
174 Outperform
9 Underperform
CAPS All Stars
 
20 Outperform
2 Underperform

How do you think Harvard Bioscience will perform against the market?



You pick for Harvard Bioscience is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jeffrey Duchemin, CEO

75% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Harvard Bioscience.

A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT